Five headlines, and how far along each really is
3 business headlines carry about ₹24,493 cr of announced money. 3 of the 3 match a company filing in our ledger. Each one sits on a ladder from an announced intention to a running plant, with why it matters, who can act on it, and what we could check.
Where the headline money stands
| BUILT | — | ||
| GROUND BROKEN | — | ||
| CONTRACTED | ₹311 cr | Steamhouse India | |
| APPROVED | — | ||
| INTENT | ₹24,182 cr | Sun Pharmaceutical Industries, Torrent Pharmaceuticals |
Headline figures, not one clean total: some are fundraising or announced intentions, and some include taxes such as GST.
Steamhouse India secures 311 crore EPC mandate
The project includes a 30 MW power facility and a 25‑year O&M mandate.
It provides a long‑term recurring revenue stream.
Suppliers, contractors, regulators.
FILING MATCHED The company's own exchange filing of 24 September states ₹311 crore and 300 TPH. It came about 3 days before the article we tracked. 4 other outlets report the same amount. Not stated in the report we read: exact location details; contractor partners.
- Economic Times (read)
- moneycontrol.com (read)
- newsx.com (read)
- thehindubusinessline.com (read)
- equitybulls.com (read)
- NSE filing, 24 Sep (Bagging/Receiving of orders/contracts) (primary source: the company's own exchange filing, read in full)
Sun Pharma announces global licensing with LIB Therapeutics
The deal covers the PCSK9 market valued at ₹30,900 crore outside the US and China, with Europe alone contributing ₹24,170 crore.
It expands Sun Pharma’s portfolio into a high‑growth PCSK9 market, potentially boosting global reach.
Suppliers, contract manufacturers, regulatory authorities, and distributors.
FILING MATCHED The company's own exchange filing of 28 September, a press release, states 300 mg/1.2 mL. 2 other outlets report the same event. Not stated in the report we read: financial terms of the agreement; timeline for product launch.
- Free Press Journal (read)
- ETPharma (the item our ledger tracked)
- equitybulls.com (read)
- medicaldialogues.in (read)
- NSE filing, 28 Sep (Press Release) (primary source: the company's own exchange filing, read in full)
Torrent Pharma raises stake in Torrent Urja
The move follows an increase in Torrent Urja's project capacity and aims to boost renewable power in Torrent Pharma's operations.
It enhances Torrent Pharma's renewable power share and ensures compliance with captive user regulations.
Suppliers, contractors, regulators.
FILING MATCHED The company's own exchange filing of 28 September, an acquisition, states 1,18,79,010. 3 other outlets report the same amount. Not stated in the report we read: regulatory approvals.
- Free Press Journal (read)
- CNBC-TV18 (the item our ledger tracked)
- thehindubusinessline.com (read)
- scanx.trade (read)
- equitybulls.com (read)
- NSE filing, 28 Sep (Acquisition) (primary source: the company's own exchange filing, read in full)
Also on the ledger (headline only, not checked further)
- NMDC Commissioned Integrated Iron Ore Project in Chhattisgarh
- Interarch Begins Production at Andhra Pradesh Plant, Raises FY28 Sales Guidance
- India’s first port‑based e‑methanol facility to add 50 t/day capacity in Phase I
- COEP Tech partners with JSW Projects on battery technology
What we watch next
- Steamhouse India: the start of work
- Sun Pharmaceutical Industries: whether land and clearances follow
- Torrent Pharmaceuticals: whether land and clearances follow
Ledger for 2026-09-28: 54 projects read (43 new, 11 follow-ups).
We're building a deeper, faster version of this for people who can act on it — more of the daily ledger, not just the five headlines, sent before the video goes out. No price yet, no charge yet: leave your email and we'll let you know when it's ready.